5 suspended. 5 Phase 3, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 5 | Suspended 5 |
| Phase 2 | 3 | Suspended 3 |
Follow Biospecimen Collection: new trials by email Literature Review of Biospecimen Collection trials Research Report on Biospecimen Collection
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Testing Low Dose Tamoxifen for Invasive Breast Cancer, LoTam Trial Anastrozole, Letrozole, Exemestane - Anatomic Stage 0 Breast Cancer AJCC v8, Anatomic Stage 1 Breast Cancer AJCC v8 | Phase 3 | Suspended | Alliance for Clinical Trials in Oncology | 1556 | 2025-02-19 | 2026-09-02 |
| Testing the Addition of an Immunotherapy Drug, Cemiplimab (REGN2810), Plus Surgery to the Usual Surgery Alone for Treating Advanced Skin Cancer Biospecimen Collection, Cemiplimab, Computed Tomography - Eyelid Squamous Cell Carcinoma, Recurrent Eyelid Squamous Cell Carcinoma | Phase 3 | Suspended | National Cancer Institute (NCI) | 420 | 2025-02-18 | 2026-10-20 |
| Testing the Addition of Radiation Therapy to the Usual Immune Therapy Treatment (Atezolizumab) for Extensive Stage Small Cell Lung Cancer, The RAPTOR Trial Atezolizumab, Biospecimen Collection, Computed Tomography - Extensive Stage Lung Small Cell Carcinoma | Phase 2 / Phase 3 | Suspended | National Cancer Institute (NCI) | 138 | 2021-01-07 | 2026-10-29 |
| Nivolumab and Ipilimumab in Treating Patients With Esophageal and Gastroesophageal Junction Adenocarcinoma Undergoing Surgery Biospecimen Collection, Carboplatin, Computed Tomography - Clinical Stage II Esophageal Adenocarcinoma AJCC v8, Clinical Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8 | Phase 2 / Phase 3 | Suspended | National Cancer Institute (NCI) | 278 | 2019-05-03 | 2026-10-22 |
| Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck Cancer Atezolizumab, Biopsy Procedure, Biospecimen Collection - Oropharyngeal p16INK4a-Negative Squamous Cell Carcinoma, Stage III Hypopharyngeal Squamous Cell Carcinoma AJCC v7 | Phase 2 / Phase 3 | Suspended | National Cancer Institute (NCI) | 613 | 2013-03-22 | 2026-10-14 |
Adenocarcinoma Of Esophagus (1) · Breast Carcinoma In Situ (1) · Carcinoma, Intraductal, Noninfiltrating (1) · Squamous Cell Carcinoma of Head and Neck (1)
National Cancer Institute (NCI) (4) · Alliance for Clinical Trials in Oncology (1)
United States (5) · Canada (2) · Australia (1) · Hong Kong (1) · Puerto Rico (1)
Jennifer R Eads (1) · Neil D Gross (1) · Paul M Harari (1) · Quynh-Nhu Nguyen (1)
U10CA180868 (3), U10CA021661 (1), U10CA180820 (1)